Systematic review of 6 randomised trials (379 adults with advanced cancer): versus placebo, systemic corticosteroids were associated with less cancer-related fatigue (SMD -0.41) and no significant rise in adverse events, all low-certainty evidence.
Meta-analysisn = 379
Kuriyama et al. Systemic Corticosteroids for Cancer-Related Fatigue in Advanced Cancer: A Systematic Review and Meta-Analysis